Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

被引：34

作者：

Kosmider, Olivier ^{[1
]}

Passet, Marie ^{[1
]}

Santini, Valeria ^{[2
]}

Platzbecker, Uwe ^{[3
]}

Andrieu, Valerie ^{[4
]}

Zini, Gina ^{[5
]}

Beyne-Rauzy, Odile ^{[6
]}

Guerci, Agnes ^{[7
]}

Masala, Erico ^{[8
]}

Balleari, Enrico ^{[9
]}

Bulycheva, Ekaterina ^{[3
]}

Dreyfus, Francois ^{[10
]}

Fenaux, Pierre ^{[11
]}

Fontenay, Michaela ^{[1
]}

Park, Sophie ^{[12
]}

机构：

[1] Hop Cochin, AP HP, Hematol Biol, Paris, France

[2] Univ Florence, AOU Careggi, Hematol, I-50121 Florence, Italy

[3] Univ Hosp Carl Gustav Dresden, Dresden, Germany

[4] Hop Bichat Claude Bernard, AP HP, Hematol Biol, Paris, France

[5] Univ Cattolica Sacro Cuore, Rome, Italy

[6] Oncopole, IUCT, Toulouse, France

[7] Hop Brabois, Nancy, France

[8] Univ Florence, Florence, Italy

[9] IRCCS AOU San Martino IST Genova, Genoa, Italy

[10] Hop Cochin, Serv Hematol, Paris, France

[11] Hop St Louis, Serv Hematol Seniors, Paris, France

[12] Univ Grenoble Alpes, CHU Grenoble Alpes, Clin Univ Hematol, Grenoble, France

来源：

HAEMATOLOGICA | 2016年 / 101卷 / 07期

关键词：

myelodysplastic syndromes; cytogenetics and molecular genetics; red cells; SURVIVAL; IMPACT; MODEL;

D O I：

10.3324/haematol.2016.142695

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：280 / 283

页数：4

共 50 条

[41] Management of patients with lower-risk myelodysplastic syndromes [J].

Brunner, Andrew M. ;

Leitch, Heather A. ;

van de Loosdrecht, Arjan A. ;

Bonadies, Nicolas .

BLOOD CANCER JOURNAL, 2022, 12 (12)

[42] Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes [J].

Teresa Cedena, M. ;

Rapado, Inmaculada ;

Santos-Lozano, Alejandro ;

Ayala, Rosa ;

Onecha, Esther ;

Abaigar, Maria ;

Such, Esperanza ;

Ramos, Fernando ;

Cervera, Jose ;

Diez-Campelo, Maria ;

Sanz, Guillermo ;

Hernandez Rivas, Jesus ;

Lucia, Alejandro ;

Martinez-Lopez, Joaquin .

ONCOTARGET, 2017, 8 (63) :106948-106961

[43] Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes [J].

Wang, Chen ;

Sallman, David. A. A. .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) :387-408

[44] Luspatercept in the treatment of lower-risk myelodysplastic syndromes [J].

Chan, Onyee ;

Komrokji, Rami S. .

FUTURE ONCOLOGY, 2021, 17 (12) :1473-1481

[45] Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes [J].

Chen Wang ;

David A. Sallman .

Current Treatment Options in Oncology, 2023, 24 :387-408

[46] How to manage lower-risk myelodysplastic syndromes [J].

Sekeres, M. A. .

LEUKEMIA, 2012, 26 (03) :390-394

[47] Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis [J].

Du, Mengyi ;

Zhou, Fen ;

Jin, Runming ;

Hu, Yu ;

Mei, Heng .

LEUKEMIA RESEARCH, 2019, 80 :11-18

[48] Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study [J].

Sekeres, Mikkael A. ;

Santini, Valeria ;

Diez-Campelo, Maria ;

Komrokji, Rami S. ;

Fenaux, Pierre ;

Savona, Michael R. ;

Madanat, Yazan F. ;

Valcarcel-Ferreiras, David ;

Oliva, Esther Natalie ;

Regnault, Antoine ;

Creel, Kristin ;

Sengupta, Nishan ;

Dougherty, Souria ;

Shah, Sheetal ;

Sun, Libo ;

Wan, Ying ;

Navada, Shyamala ;

Zeidan, Amer M. ;

Platzbecker, Uwe .

LEUKEMIA & LYMPHOMA, 2025, 66 (03) :529-534

[49] A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry [J].

Houston, Brett L. ;

Jayakar, Jennifer ;

Wells, Richard A. ;

Lenis, Martha ;

Zhang, Liying ;

Zhu, Nancy ;

Leitch, Heather A. ;

Nevill, Thomas J. ;

Yee, Karen W. L. ;

Leber, Brian ;

Sabloff, Mitchell ;

St-Hilaire, Eve ;

Kumar, Rajat ;

Geddes, Michelle ;

Shamy, April ;

Storring, John M. ;

Keating, Mary-Margaret ;

Elemary, Mohamed ;

Delage, Robert ;

Mamedov, Alex ;

Buckstein, Rena .

ANNALS OF HEMATOLOGY, 2017, 96 (12) :2025-2029

[50] Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial [J].

Garcia-Manero, Guillermo ;

Santini, Valeria ;

Zeidan, Amer M. ;

Komrokji, Rami S. ;

Pozharskaya, Veronika ;

Rose, Shelonitda ;

Keeperman, Karen ;

Lai, Yinzhi ;

Kalsekar, Sameer ;

Aggarwal, Barkha ;

Miteva, Dimana ;

Valcarcel, David ;

Fenaux, Pierre ;

Shortt, Jake ;

Della Porta, Matteo Giovanni ;

Platzbecker, Uwe .

ADVANCES IN THERAPY, 2025, 42 (07) :3576-3589

← 1 2 3 4 5 →